These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5417223)

  • 1. Effect of hexylguanidine on cardiovascular system and blood glucose.
    Ozawa H; Sugawara K
    Chem Pharm Bull (Tokyo); 1970 Jan; 18(1):14-21. PubMed ID: 5417223
    [No Abstract]   [Full Text] [Related]  

  • 2. Cocaine-like actions of hexylguanidine.
    Ozawa H; Sugawara K
    Jpn J Pharmacol; 1969 Sep; 19(3):343-53. PubMed ID: 5307467
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular actions of cyclohexylammonium 3,6-pyridazinediolate.
    Tam L; Yen MH; Chow SY
    Taiwan Yi Xue Hui Za Zhi; 1975 Jul; 74(7):480-8. PubMed ID: 1059730
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-activity relationship of alkylguanidines on smooth muscle organs.
    Ozawa H; Sugawara K
    Chem Pharm Bull (Tokyo); 1968 Dec; 16(12):2376-82. PubMed ID: 5719027
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological studies of aminoguanidines. II. Analysis of pharmacological action of 3,4-dihydroxy-5-methoxybenzoylamino-guanidine (AG-2H) on cardiovascular system].
    Ozawa H; Katsuragi T
    Yakugaku Zasshi; 1972 Sep; 92(9):1095-100. PubMed ID: 4674824
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular action of mesoionic compounds, 3-substituted sydnonimines.
    Kikuchi K; Hirata M; Nagaoka A; Aramaki Y
    Jpn J Pharmacol; 1970 Mar; 20(1):23-43. PubMed ID: 5311326
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonistic phenomena between crystalline tetrodotoxin and guanidines on sympathetic nervous systems.
    Ozawa H; Sugawara K
    Chem Pharm Bull (Tokyo); 1969 Aug; 17(8):1605-10. PubMed ID: 5348889
    [No Abstract]   [Full Text] [Related]  

  • 8. [On relations between the distribution of electrons in monoguanylhydrazones and their pharmacological action].
    Mutschler E; Scherf H; Voss P; Wassermann O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(3):367-82. PubMed ID: 4231693
    [No Abstract]   [Full Text] [Related]  

  • 9. The preparation and properties of (+)- and (--)-guanoxan.
    Stenlake JB; Breimer DD; Smail GA; Stafford A; Bowman WC
    J Pharm Pharmacol; 1968 Dec; 20():Suppl:82S+. PubMed ID: 4388179
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Inhibition of effects of accelerator nerve stimulation in cats and rabbits by BS 100-141 and guanabenz.
    Scholtysik G
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R86. PubMed ID: 4276642
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the pharmacology of N-(2-guanidinoethyl)-4-methyl-1,2,3,6-tetrahydropyridine, a new antihypertensive-acting compound].
    Kroneberg G; Schlossmann K; Stoepel K
    Arzneimittelforschung; 1967 Feb; 17(2):199-207. PubMed ID: 5631784
    [No Abstract]   [Full Text] [Related]  

  • 12. The adrenergic neurone blocking action of [2-(methylphenylamino)ethyl]guanidine sulfate. I.
    Ozawa H; Sato S
    Chem Pharm Bull (Tokyo); 1966 Nov; 14(11):1291-7. PubMed ID: 5979175
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypotensive activity of beta-heptamethylenimino-ethylaminoguanidine sulfate.
    Botton I; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1966 May; 152(2):243-50. PubMed ID: 5944368
    [No Abstract]   [Full Text] [Related]  

  • 14. New norepinephrine-depleting agents. Beta-hydroxyphenethylguanidine and related compounds.
    Green AL; Fielden R; Bartlett DC; Cozens MJ; Eden RJ; Hills DW
    J Med Chem; 1967 Nov; 10(6):1006-8. PubMed ID: 6056024
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of supersensitivity to catecholamines following chloroquine.
    Pandya KH; Jindal MN; Kelkar VV
    Arzneimittelforschung; 1968 Jul; 18(7):786-90. PubMed ID: 5755820
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sympathomimetic effects of cyclohexylamine].
    Classen HG; Marquardt P; Späth M
    Arzneimittelforschung; 1968 May; 18(5):590-4. PubMed ID: 5755888
    [No Abstract]   [Full Text] [Related]  

  • 17. Centrally mediated cardiovascular effects of angiotensin II.
    Smookler HH; Severs WB; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1966 Sep; 153(3):485-94. PubMed ID: 4288411
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of the effects of some new derivatives of ethylenediamine on the cardiovascular system. Studies on general pharmacological properties.
    Filczewski M
    Acta Physiol Pol; 1974; 25(6):565-76. PubMed ID: 4456970
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of guanethidine and cyclazenine on the sympathomimetic effect of cyclohexylamine].
    Classen HG
    Arzneimittelforschung; 1969 Jun; 19(6):929-32. PubMed ID: 5820405
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of new guanidine derivatives on ganglionic and neuromuscular transmission.
    Kadzielawa K; Gumulka W
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):297-309. PubMed ID: 4294771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.